Orbia Advance Corporation, S.A.B. de C.V. Unsponsored ADR (OTCMKTS:MXCHY - Get Free Report)'s share price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $1.40 and traded as low as $1.35. Orbia Advance shares last traded at $1.51, with a volume of 415 shares.
Analyst Upgrades and Downgrades
Separately, Barclays reissued an "overweight" rating on shares of Orbia Advance in a report on Tuesday, May 6th.
Read Our Latest Stock Report on MXCHY
Orbia Advance Stock Up 3.1%
The firm's 50-day moving average price is $1.36 and its two-hundred day moving average price is $1.40. The company has a current ratio of 1.36, a quick ratio of 0.93 and a debt-to-equity ratio of 1.48.
Orbia Advance Company Profile
(
Get Free Report)
Orbia Advance Corporation, SAB. de C.V. provides products and solutions for precision agriculture, building and infrastructure, fluorinated, polymer, and connectivity sectors worldwide. The company offers irrigation systems, agricultural and greenhouse projects, digital farming technologies, and related services; and connectivity solutions, including conduits, cable-in conduit, and other HDPE products and solutions.
Recommended Stories
Before you consider Orbia Advance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Orbia Advance wasn't on the list.
While Orbia Advance currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.